+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Effects of diethyldithiocarbamate and structural analogs in mice with systemic candidal infections

Effects of diethyldithiocarbamate and structural analogs in mice with systemic candidal infections

Research Communications in Chemical Pathology and Pharmacology 56(2): 253-263

Three different substituted dithiocarbamates: sodium diethyl-dithiocarbamate (DDTC), sodium dimethyldithiocarbamate (DmDTC), and sodium N-methyl-D-glucamine dithiocarbamate (NMG-DTC) were evaluated for their ability to combat the growth and development of three human pathogenic strains of Candida albicans, in vitro and in vivo, in mice. DDTC and DmDTC produced marked growth inhibition on agar plates, in vitro, of three different strains of Candida albicans, while NMG-DTC displayed little inhibitory effect. Low, nontoxic doses of each compound administered to immunosuppressed mice exhibited impressive therapeutic effects in treating candidiasis. NMG-DTC showed the best consistent therapeutic antifungal effect against Candida albicans in mice immunosuppressed with Solu-MedrolR. Combinations of low doses of DDTC and Amphotericin-B appeared to be effective in treating systemic candidial infections, and the results suggested that these combinations may offer therapeutic advantages over those produced by the use of either agent alone.

(PDF emailed within 1 workday: $29.90)

Accession: 001580461

Download citation: RISBibTeXText

PMID: 3037656

Related references

Effects of diethyldithiocarbamate and selected analogs on lead metabolism in mice. Research Communications in Chemical Pathology and Pharmacology 52(1): 29-44, 1986

Systemic candidal infections in neonates. Clinical Infectious Diseases 15(3): 554-554, 1992

Management of systemic candidal infections in the intensive care unit. American Journal of Health-System Pharmacy 59(1): 33-41, 2002

Local and systemic host defense mechanisms against Candida: immunopathology of candidal infections. Pediatric Infectious Disease Journal 16(8): 795-801, 1997

Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience. Clinical Infectious Diseases 14(2): 485-491, 1992

Maturation of T-Cell Response To Antigen In a Male Child With Recurrent Systemic Candidal Infections. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY [Author] The 9th International Congress of Immunology : 380, 1995

Effects of a series of purine analogs on Friend leukemia virus infections in mice. Cancer Research 28(1): 35-40, 1968

Studies on defence effects of recombinant human granulocyte colony-stimulating factor (G-CSF) to infections. III. Protective effect on pulmonary and systemic infections of P. aeruginosa in neutropenic mice. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 64(5): 604-611, 1990

Structural analogs of pyrazole and sulfonamide cannabinoids: effects on acute food intake in mice. European Journal of Pharmacology 695(1-3): 62-70, 2013

Small constrained SP1-7 analogs bind to a unique site and promote anti-allodynic effects following systemic injection in mice. Neuroscience 298: 112-119, 2016

Combination effects between KW-2228 and antibiotics against systemic infections in normal and neutropenic mice. Japanese Journal of Antibiotics 45(1): 91-97, 1992

Effects of diethyldithiocarbamate and selected analogs on cadmium metabolism following chronic cadmium ingestion. Research Communications in Chemical Pathology and Pharmacology 47(1): 107-114, 1985

In vivo effects of diethyldithiocarbamate of autoimmune mrl 1pr 1pr mice. Clinical Research 37(1): 123A, 1989

In vivo effects of diethyldithiocarbamate on autoimmune mlr lpr lpr mice. Clinical Research 37(2): 508A, 1989